Piramal Pharma's Pharma Solutions business, a leading Contract Development and Manufacturing Organization (CDMO) held a grand opening to celebrate the official inauguration of a new active pharmaceutical ingredient (API) plant at the company's site in Aurora, Ontario.

The event was attended by members of the PPS Aurora Site Leadership Team, the company's global Executive Leadership Team, and several Aurora dignitaries, including the Honorable Tom Mrakas, Mayor of Aurora; Aurora Town Councilors Sandra Humfryes and Rachel Gilliland; Lisa Hausz, Manager of Economic Development & Policy for Aurora, and Seanna Murray of the Aurora Chamber of Commerce.

The new plant, built as part of a CAD 30 million capital investment in the Aurora site, features more than ten thousand square feet of new manufacturing space and includes two new reactor suites with additional filtration and drying capabilities. It will support ongoing customer demand for Piramal Pharma Solutions' expertise in APIs and enhances and expands the company's ability to produce clinical to commercial scale APIs, including highly potent APIs requiring an Occupational Exposure Limit (OEL) of 1mcg/m3.

Peter DeYoung, CEO, Piramal Pharma Solutions said, "This new plant is just the latest in a series of expansions and capability upgrades at Aurora, with more to follow. I thank the local government for their support. In partnership with them, the team at Aurora has done commendable work in getting this facility engineered and online. It's evidence of our commitment to the global API market and the long-term growth of PPS as an organization. Our ultimate objective is to help customers get medicines to patients, and Aurora is an important part of that process. What's been accomplished to date in Aurora is indeed a source of pride for all of us, and we look forward to what's yet to come."